Marc L. Steuer
Overview
Marc L. Steuer received an average of $435K in total compensation, including $275K in salary, at MabVax Therapeutics Holdings from 2006 to 2012.
2012MabVax Therapeutics HoldingsFormer Senior Vice President, Business Development
2011MabVax Therapeutics HoldingsFormer Senior Vice President, Business Development
2010MabVax Therapeutics HoldingsSenior Vice President, Business Development
2009MabVax Therapeutics HoldingsSenior Vice President, Business Development
2008MabVax Therapeutics HoldingsSenior Vice President, Business Development
2007MabVax Therapeutics HoldingsSenior Vice President, Business Development
2006MabVax Therapeutics HoldingsSenior Vice President, Business Development
Source: SEC filings on April 5, 2013, March 5, 2012, April 7, 2010, and April 10, 2009.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
Paul Resnick
MabVax Therapeutics Holdings
Vice President, Chief Business Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings